Oncotarget

Research Papers:

Recombinant frizzled1 protein attenuated cardiac hypertrophy after myocardial infarction via the canonical Wnt signaling pathway

Jingjing Fan, Lin Qiu, Hongyang Shu, Ben Ma, Marco Hagenmueller, Johannes H. Riffel, Soeren Meryer, Min Zhang, Stefan E. Hardt, Lin Wang, Ning Zhou _, Hongyu Qiu and Ning Zhou _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:3069-3080. https://doi.org/10.18632/oncotarget.23149

Metrics: PDF 2100 views  |   HTML 2543 views  |   ?  


Abstract

Jingjing Fan1,2, Lin Qiu3, Hongyang Shu1, Ben Ma4, Marco Hagenmueller2, Johannes H. Riffel2, Soeren Meryer2, Min Zhang2, Stefan E. Hardt2, Lin Wang1, Dao Wen Wang1, Hongyu Qiu4 and Ning Zhou1

1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China

2Department of Cardiology, University of Heidelberg, Heidelberg, Germany

3Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China

4Division of Physiology, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA

Correspondence to:

Ning Zhou, email: [email protected]

Hongyu Qiu, email: [email protected]

Keywords: frizzled1; cardiac hypertrophy; myocardial infarction; wnt signaling pathway; recombinant protein

Received: March 14, 2017     Accepted: November 15, 2017     Published: December 12, 2017

ABSTRACT

Postinfarct cardiac hypertrophy is an independent risk factor for heart failure and sudden death. Regression of cardiac hypertrophy has emerged as a promising strategy in the treatment of myocardial infarction (MI). Here we hypothesized that frizzled1 (FZD1), a receptor of the canonical Wnt signaling pathway, is a novel mediator of ischemia-associated cardiac hypertrophy. MI was induced in mice by left anterior descending (LAD) coronary occlusion. One week after MI, the expression of FZD1 was found to be notably increased in the left ventricles (LVs) of the MI-mice compared to shams. Mouse recombinant FZD1 protein (RFP) was subcutaneously injected in the mice to provoke autoimmunization response. Anti-FZD1 antibody titer was significantly increased in the plasma of RFP-treated mice. RFP significantly mitigated the MI-induced cardiac hypertrophy and improved cardiac function in the MI mouse hearts. Moreover, increased heart and LV weights, myocardial size and the expression of β-myosin heavy chain in the MI-mice were also found to be attenuated by RFP. FZD1 was found to be significantly up-regulated in hypoxia-treated neonatal rat cardiomyocytes (NRCMs). Silencing FZD1 by siRNA transfection notably repressed the hypoxia-induced myocardial hypertrophy in NRCMs. Mechanistically, activation of canonical Wnt signaling induced by MI, e.g., β-catenin and glycogen synthase kinase-3β, was restrained in the LVs of the MI-mice treated by RFP, these inhibition on canonical Wnt signaling was further confirmed in hypoxic NRCMs transfected with FZD1 siRNA. In conclusion, immunization of RFP attenuated cardiac hypertrophy and improved cardiac function in the MI mice via blocking the canonical Wnt signaling pathway.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23149